United States

Becton, Dickinson and Company BDX

NYSE Health technology USD

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells a wide range of medical devices, instrument systems, and reagents. The company operates through three primary segments: Medical, Life Sciences, and Interventional. BD's Medical segment focuses on medication delivery and management solutions, including intravenous catheters, infusion pumps, and prefillable drug delivery systems. The Life Sciences segment provides products for specimen collection, diagnostics, and biosciences research, such as blood collection systems, microbiology testing platforms, and cell analysis tools. The Interventional segment offers surgical, peripheral intervention, and urology products for various medical procedures. BD serves healthcare institutions, laboratories, pharmaceutical companies, and research organizations worldwide, generating revenue through the sale of its medical products and associated services.

Current Price USD 188.82
Daily Change -0.36%
Market Cap USD 53.89 B
Shares Outstanding 285.42 M
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart